Contact us

Our latest news

Back to news >

New Senior Principal Scientist – Alison Wilby

Exciting Announcement: Appointment of Senior Principal Scientist! 

We are thrilled to announce the appointment of Alison Wilby as our new Senior Principal Scientist in Clinical Pharmacology and DMPK. With an impressive background and a wealth of experience in her field, Alison brings a remarkable level of knowledge and expertise to Seda. 

Alison expands our capacity and deepens our technical expertise in Clinical Pharmacology and DMPK consultancy support to guide client projects from late phase discovery through to clinical development, including dose selection, dose justification and drug-drug interaction (DDI) support.  This can be a difficult skillset for biotech clients to access and is critical for speedy clinical development. Alison is a world leader in Physiologically Based Biopharmaceutics modelling (PBBM) and PBPK. The expertise Alison brings allows us to offer clients late-stage regulatory PBBM and PBPK modelling, including GastroPlus(R). 

Alison has a PhD in Drug Metabolism from the University of Manchester and an MSc in Toxicology from the University of Birmingham. She is an experienced multidisciplinary scientist having spent over 10 years in Discovery DMPK with AstraZeneca and, for the last 10 years, specialised in PBPK modelling using GastroPlus with Quotient Sciences.  

At Seda Alison will be working within the modelling team to provide scientific Clinical Pharmacology and DMPK input, study design and providing interpretation and analysis of client data. 

As a Senior Principal Scientist, Alison will play a pivotal role in driving our scientific endeavours, spearheading research initiatives, and guiding our talented team of modellers. Her extensive experience and exceptional track record in clinical pharmacology and DMPK makes her an invaluable addition to the Seda team. 

Alison’s appointment aligns perfectly with Seda’s vision and commitment to fostering a culture of innovation and scientific excellence. With Alison’s leadership, we are excited to explore new research avenues, forge strategic collaborations, and make significant contributions to support our esteemed clients. 

Please join us in congratulating Alison on her new role as Senior Principal Scientist: Clinical Pharmacology and DMPK.